This course has expired. View available courses.
Diabète
Pharmacothérapie pour le diabète de type 2 selon les lignes directrices 2018 de Diabète Canada – Mainpro+
DURATION
PROFESSION
Physician
# OF CREDITS
2
ACCREDITATION
Mainpro+
EXPIRY DATE
2019-08-20
Learning objectives
Après avoir complété ce programme de formation continue, le clinicien sera mieux en mesure de :
- Cerner l’importance d’une approche multifactorielle à la pharmacothérapie pour la prise en charge du diabète de type 2, incluant la maîtrise glycémique, la réduction du poids corporel, l’accroissement de l’activité physique, l’amélioration de la dyslipidémie et la réduction du risque CV;
- Comprendre l’importance du poids corporel dans la prise en charge du diabète de type 2 et son incidence sur le choix d’un agent antihyperglycémiant;
- Faciliter la prise de décision clinique lorsqu’il vient temps de sélectionner la classe de médicament appropriée pour un patient particulier;
- Distinguer les agonistes des récepteurs du GLP-1 des inhibiteurs du SGLT2 en ce qui concerne leurs effets sur la réduction du risque vasculaire;
- Connaître l’icidence que peuvent avoir la fragilité et les degrés de fonction rénale sur la prise en charge du diabète de type 2.
# of credits: 2
Duration:
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
